Download PDF
Thromb Haemost 1985; 54(04): 750-755
DOI: 10.1055/s-0038-1660125
Original Article
Schattauer GmbH Stuttgart

Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators[*]

M Kopitar
1   The Department of Biochemistry, J. Stefan Institute, Ljubljana, Yugoslavia
,
B Rozman
2   The Medical Faculty, E. Kardelj University of Ljubljana, Ljubljana, Yugoslavia
,
J Babnik
1   The Department of Biochemistry, J. Stefan Institute, Ljubljana, Yugoslavia
,
V Turk
1   The Department of Biochemistry, J. Stefan Institute, Ljubljana, Yugoslavia
,
D E Mullins
3   The Department of Cell Biology, New York University Medical Center, New York, N.Y., USA
,
T C Wun
4   The Rockefeller University, New York, N.Y., USA
› Author Affiliations
Further Information

Publication History

Received 19 February 1985

Accepted 12 August 1985

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

A plasminogen activator inhibitor (PA-I) which inhibits primarily plasminogen activator of the urokinase type (u-PA) was isolated from the cytosol of human peripheral leukocytes. The inhibitor was isolated using ion exchange chromatography, gel filtration and FPLC. This inhibitor has an apparent molecular weight of 45 kDa, determined by SDS-PAGE, and a pi of 5.5-5.7. The inhibitor is a fast reacting inhibitor, is thermally unstable and is inactivated outside the pH range 7-9. Treatment of cytosol to pH 9 for 30 min at 37° C resulted in a large increase in inhibitory activity. Antibodies against human placental UK-I completely quenched the inhibitory activity of human leucocyte UK-I.

Keywords

Human leukocyte plasminogen activator inhibitor (PA-I) - Isolation procedure - Biochemical characteristics - Immunological identity with human placental urokinase inhibitor

* Supported by a grant from the Research Council of Slovenia and 3by a grant from the National Cancer Institute (CA 23753) to D. B. Rifkin


 

  • References

  • 1 Reddy KN N, Kline DL. Plasminogen activators. In: Fibrinolysis Kline and Reddy. pp 25-41 CRC Press; Boca Raton, Florida: 1980
  • 2 Hoal EG, Wilson EL, Dowdle EB. The regulation of tissue plasminogen activator activity by human fibroblasts. Cell 1983; 34: 273-279
    CrossrefPubMedGoogle Scholar
  • 3 Kluft C, Jie AF H, Allen RA. Behaviour and quantitation of extrinsic (tissue type) plasminogen activator in human blood. Thromb Haemostas 1983; 50: 518-523
    PubMedGoogle Scholar
  • 4 Kawano T, Morimoto L, Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. Jpn Biochem 1970; 67: 333-342
    PubMedGoogle Scholar
  • 5 Holmberg L, Lecander I, Person B, Astedt B. An inhibitor from placenta specifically binds UK and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta 1978; 544: 128-137
    CrossrefPubMedGoogle Scholar
  • 6 Terao T, Kobayashi T. The role of placental urokinase inhibitor in toxemia pregnancy. Biol Res Pregn 1983; 4: 145-151
    PubMedGoogle Scholar
  • 7 Kopitar M. Isolation and some characteristics of urokinase inhibitors from pig leucocytes. Haemostasis 1981; 10: 215-232
    PubMedGoogle Scholar
  • 8 Hibino T, Izaki S, Izaki M. Detection of serine proteinase inhibitors in human cornified cells. Biochem Biophys Res Commun 1981; 101: 948-955
    CrossrefPubMedGoogle Scholar
  • 9 Aoki N, Kawano T. Inhibition of plasminogen activators by natural occurring inhibitors in man. Am J Physiol 1972; 223: 1334-1337
    PubMedGoogle Scholar
  • 10 Korninger C, Collen D. Neutralization of human extrinsic (tissue type) plasminogen activator in human plasma: No evidence for a specific inhibitor. Thromb Haemostas 1981; 46: 662-665
    PubMedGoogle Scholar
  • 11 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 12 Kruithof EK O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
    PubMedGoogle Scholar
  • 13 Loskutoff DJ, Edgington TS. An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem 1981; 256: 4142-4145
    PubMedGoogle Scholar
  • 14 Birkedal-Hansen H, Taylor RE. Production of three plasminogen activators and an inhibitor in keratinocyte cultures. Biochim Biophys Acta 1983; 756: 308-318
    CrossrefPubMedGoogle Scholar
  • 15 Emeis JJ, van Hinsberg VW M, Verheijen JH, Wijngaards G. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun 1983; 110: 392-398
    CrossrefPubMedGoogle Scholar
  • 16 Baugh RJ, Travis J. Human leucocyte granule elastases. Rapid isolation and characterization. Biochemistry 1976; 15: 836-841
    CrossrefPubMedGoogle Scholar
  • 17 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedGoogle Scholar
  • 18 Pharmacia booklet: Polyacrylamide gel electrophoresis techniques. Uppsala; Sweden: 1981
    Google Scholar
  • 19 Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4 . Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 20 Righetti PG, Drysdale JW. Isoelectric focusing in gels. J Chromatogr 1975; 98: 271-321
    PubMedGoogle Scholar
  • 21 Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med 1973; 137: 085-112
    CrossrefPubMedGoogle Scholar
  • 22 Erlanger BF, Kokowsky N, Collen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961; 95: 271-278
    CrossrefPubMedGoogle Scholar
  • 23 Babnik J, Kopitar M, Turk V. Immunochemistry of leucocyte intracellular proteinase inhibitors. Mol Immunol 1983; 20: 263-269
    CrossrefPubMedGoogle Scholar
  • 24 Ouchterlony O. Immunodiffusion and immunoelectrophoresis. In: Handbook of experimental immunology. Weir, 2nd ed Blackwell Scientific Press; Oxford: 1973: 19.01-19.39
  • 25 Laurell CB. Antigen-antibody crossed electrophoresis. Anal Biochem 1965; 10: 358-361
    CrossrefPubMedGoogle Scholar
  • 26 Kopitar M, Brzin J, Babnik J, Turk V, Suhar A. Intracellular neutral proteinases and their inhibitors. In: Mildner, Ries, Proc. Spec. FEBS Meeting on Enzymes 60, Dubrovnik-Cavtat 1979 Pergamon Press; Oxford: 1980. pp 363-375
  • 27 Unkeless JC, Dano K, Kellerman GM, Reich E. Fibrinolysis associated with oncogenic transformation. J Biol Chem 1974; 249: 4295-4305
    PubMedGoogle Scholar
  • 28 Quigley JP. Association of a protease (plasminogen activator) with a specific membrane fraction from transformed cell. J Cell Biol 1976; 71: 472-486
    CrossrefPubMedGoogle Scholar
  • 29 O’Donnell-Tormey J, Quigley JP. Detection and partial characterization of a chymostatin sensitive endopeptidase in transformed fibroblasts. Proc Nat Acad Sci (USA) 1983; 80: 344-348
    CrossrefPubMedGoogle Scholar
  • 30 Crutchley DS, Conanan LB, Maynard JR. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids. Ann N Y Acad Sci 1981; 370: 609-616
    CrossrefPubMedGoogle Scholar
  • 31 Mullins DE, Bazer FW, Roberts RM. Secretion of a progesterone-induced inhibitor of plasminogen activator by the porcine uterus. Cell 1980; 20: 865-872
    CrossrefPubMedGoogle Scholar
  • 32 Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983; 695: 177-214
    PubMedGoogle Scholar
  • 33 Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983; 35: 611-619
    CrossrefPubMedGoogle Scholar
  • 34 Giraldi T, Kopitar M, Sava G. Antimetastatic effects of a leucocyte intracellular inhibitor of neutral proteases. Cancer Res 1977; 37: 3834-3835
    PubMedGoogle Scholar
  • 35 Giraldi T, Sava G, Kopitar M, Brzin J, Turk V. Neutral proteinase inhibitors and antimetastatic effect in mice. Eur J Cancer 1980; 16: 449-454
    CrossrefPubMedGoogle Scholar
  • 36 Pavelič K, Sirotkovič M, Kopitar M, Pavelič J, Vuk-Pavlovič S. Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leucocytes. Eur J Cancer Clin Oncol 1983; 19: 123-126
    CrossrefPubMedGoogle Scholar